“Assessment of Neuregulin4 Function in Patients With Polycystic Ovary Syndrome Disorder”. Journal of Pharmaceutical Negative Results, vol. 13, no. 4, Oct. 2022, pp. 676-8, https://doi.org/10.47750/pnr.2022.13.04.090.